NYMOX PHARMACEUTICAL CORPORATION Adjustments For Finance Income
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) reported Adjustments For Finance Income of $17.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-06-03.
Financial Statements › Income Statement › Other Income
ifrs-full:AdjustmentsForFinanceIncome · last filed 2025-06-03
- NYMOX PHARMACEUTICAL CORPORATION adjustments for finance income for the quarter ending 2021-03-31 was $1.00K, a 96.00% decline year-over-year.
- NYMOX PHARMACEUTICAL CORPORATION adjustments for finance income for the quarter ending 2020-03-31 was $25.00K.
| Period end | Adjustments For Finance Income 3 month | Adjustments For Finance Income 12 month |
|---|---|---|
| 2024-12-31 | $17.00K 20-F · filed 2025-06-03 | |
| 2023-12-31 | $7.00K 20-F · filed 2025-06-03 | |
| 2022-12-31 | $6.00K 20-F · filed 2025-06-03 | |
| 2021-12-31 | $6.00K 20-F · filed 2024-08-29 | |
| 2021-03-31 | $1.00K 6-K · filed 2021-05-14 | |
| 2020-12-31 | $24.00K 20-F · filed 2023-05-02 | |
| 2020-03-31 | $25.00K 6-K · filed 2021-05-14 | |
| 2019-12-31 | $201.00K 20-F · filed 2022-03-30 | |
| 2018-12-31 | $65.00K 20-F · filed 2021-03-29 | |
| 2017-12-31 | $10.00K 20-F · filed 2020-03-30 | |
| 2016-12-31 | $4.00K 20-F · filed 2019-03-29 |